The Food and Drug Administration approved Flow Neuroscience’s at-home brain stimulation device for t...
On Friday, the Food and Drug Administration (FDA) announced that it is permitting the marketing of t...
Yesterday the U.S. Food and Drug Administration (FDA) approved Zulresso (brexanolone) for the treatm...
The Food and Drug Administration (FDA) has approved Latuda (lurasidone HCl) for the treatment of dep...
Two devices for assessing cognitive function immediately following a suspected brain injury or concu...
The Food and Drug Administration (FDA) last week approved Vraylar (cariprazine), a dopamine D2/D3 re...
The FDA has approved Invega Trinza (paliperidone palmitate), a long-acting atypical antipsychotic in...
